The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

The headlines about Prince's reported painkiller addiction have captured the nation's attention, but the stats on America's opioid crisis show that it's in no way surprising. Opioid addiction claimed 28,000 deaths in 2014, half from painkiller prescriptions, the...

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

CNBC Published on Sep 7, 2016 Proove Biosciences has developed a series of medical tests that can show a doctor who is at a high risk for developing addiction to opioid painkillers. » Subscribe to CNBC: http://cnb.cx/SubscribeCNBC About CNBC: From 'Wall...

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

PRConsultant Published on Feb 19, 2016 With prescription drug and heroin overdoses now killing more Americans than car accidents, the opioid crisis has worked its way into the speeches of presidential candidates and a billion dollar plan by President...

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

Proove Biosciences Announces Sponsorship of National Drug Take Back Day and HC DrugFree IRVINE, CA (PRWEB) October 24, 2013 Proove Biosciences, the leader in personalized pain medication innovation, is proud to be a Silver Sponsor partner of HC DrugFree and...

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

Proove Biosciences' Presented Research on the Predictive Risk of Workers Compensation Claims Extending Beyond One Year Irvine, CA (PRWEB) April 15, 2014 Proove Biosciences, the leader in Personalized Pain Medicine testing services, exhibited and presented three...

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

Low Tolerance for Pain? The Reason May Be In Your Genes Apr 21, 2014, 15:15 ET from American Academy of Neurology ------------------------------------------------------------------------------------------------------- PHILADELPHIA, April 21,...

« Older Entries

February 9, 2016 – Proove Release: Proove Presents Data at Leading Scientific Meeting

by admin | February 12, 2018 | In the News | 0 Comments

(PRWEB) February 19, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, presented findings on the link between genetics and pain at the American Academy of Pain Management's (AAPM) 32nd Annual Meeting. As the only company...

March 15, 2017 – Proove Release: Published Case Study Shows How Leading Orthopedic Surgeon Uses Proove Technology to Improve Patient Care

by admin | February 12, 2018 | Press Releases | 0 Comments

Post-Operative Orthopedic Surgery Study Using Precision Medicine Platform Published in the Journal of Medical Case Reports Demonstrates How Proove Profiles Are Used to Improve Outcomes IRVINE, Calif., March 15, 2017 /PRNewswire/ -- Proove Biosciences, Inc. announces...

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

by admin | February 12, 2018 | In the News | 0 Comments

The new Proove Non-Opioid Pain Medication Response profile evaluates genetic factors to predict a patient’s response to non opioids before prescribing Irvine, CA (PRWEB) - Proove Biosciences, a commercial and research leader in Personalized Medicine, is excited to...

March 30, 2016 – Proove Release: Proove Expands Sales Force

by admin | February 12, 2018 | Press Releases | 0 Comments

IRVINE, CA (PRWEB) MARCH 30, 2016 Proove Biosciences, Inc., the commercial and research leader in personalized pain medicine, is excited to announce the expansion of its salesforce. Building on record growth, Proove Biosciences is expanding its network of authorized...

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

by admin | February 12, 2018 | In the News | 0 Comments

Irvine, CA (PRWEB) July 14, 2015 Proove Biosciences, a commercial and research leader in Personalized Medicine, recently presented data on three ground-breaking scientific studies at the Neurological Disorders Summit in San Francisco, CA. The Neurological Disorders...

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

by admin | February 12, 2018 | Press Releases | 0 Comments

Proove Biosciences Closes on the Acquisition of Pain Genetics Firm Algynomics Proove Biosciences, Inc. today announced it has closed on a definitive agreement to acquire Algynomics, a research-stage pain diagnostics company. The Algynomics platform and its patient...

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

by admin | February 12, 2018 | Press Releases | 0 Comments

(PRWEB) APRIL 07, 2015 Proove Biosciences a commercial and research leader in Personalized Medicine, is excited to announce the launch of Proove Opioid Response - the world’s first clinical laboratory test to predict responders to opioid pain medications. Building on...

May 31, 2017 – Proove Release: Preliminary Results from Large Clinical Utility Study of Over 27,000 Patients Shows 90% of Patients Experience Significant Pain Reduction From Decisions Made with Proove Technology

by admin | February 12, 2018 | Press Releases | 0 Comments

Preliminary Results of 27,659 patients from MOSAIC Trial Demonstrate that Proove® Technology Leads to Better Patient Outcomes IRVINE, Calif., May 31, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces preliminary results at the close of a large patient-centered...

April 19, 2017 – Proove Release: First Published Study of Precision Medicine to Predict Opioid Abuse

by admin | February 12, 2018 | Press Releases | 0 Comments

Results Published in the Journal Pharmacogenomics and Personalized Medicine Shows Proove Opioid Risk® Accurately Identifies Prescription Opioid Abuse Risk IRVINE, Calif., April 19, 2017 /PRNewswire/ -- As a Bronze Sponsor of the National Rx Drug Abuse and Heroin...

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

by admin | February 12, 2018 | Press Releases | 0 Comments

New Peer-Reviewed Prospective Study Shows that Proove Opioid Risk® Profile Results in Better Pain Management Decisions Providing a 50% Reduction in Pain IRVINE, Calif., Aug. 2, 2017 /PRNewswire/ -- Proove® Biosciences, Inc. announces yet another new...

Get Instant Access to Updates to The Truth about Proove Bio

Success!

Last Name

The Acheivement’s of Proove Bio

News and Media

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

October 24, 2013 – Proove Release: Proove Sponsors National Take Back Day

April 15, 2014 – Proove Release: Proove Wins Award from American Society of Interventional Pain Physicians for Its Research

April 21, 2014 – Issued by the American Academy of Neurology recognizing Proove’s quality research

February 9, 2016 – Proove Release: Proove Presents Data at Leading Scientific Meeting

March 15, 2017 – Proove Release: Published Case Study Shows How Leading Orthopedic Surgeon Uses Proove Technology to Improve Patient Care

April 23, 2015 – Proove Release: Proove Biosciences Launches World's First Test To Predict Responders To Commonly Prescribed Non-Opioid Pain Medications

March 30, 2016 – Proove Release: Proove Expands Sales Force

July 14, 2015 – Proove Release: Proove Biosciences Presents Research Studies at Neurological Disorders Summit in San Francisco, CA

May 5, 2016 – Proove Release: Proove Acquires Algynomics Founded by Leading Researchers in the Field of Pain Genetics

April 7, 2015 – Proove Release: Proove Launches Opioid Response Test

May 31, 2017 – Proove Release: Preliminary Results from Large Clinical Utility Study of Over 27,000 Patients Shows 90% of Patients Experience Significant Pain Reduction From Decisions Made with Proove Technology

April 19, 2017 – Proove Release: First Published Study of Precision Medicine to Predict Opioid Abuse

August 2, 2017 | Proove Release: 7 th Published Peer-Reviewed Study in Last 7 Months Supports Proove Technology to Predict Opioid Abuse

Video’s

A medical test that aims to wean America off painkillers

Genetic Test Can Help Prevent America’s Opioid Painkiller Addiction | The Pulse | CNBC

News Conference at APPM Regarding Presidential Candidates, Doctors, and Opioid Abuse

OC Tech Alliance High Tech Innovation Awards 2015

SmartCEO Magazine Corporate Culture Awards in 2015

2016 Baltimore Future 50 Awards – Group 5

Get Instant Access to Updates to The Truth about Proove Bio

Success!